Cargando…
Review of Hydroxychloroquine Cardiotoxicity: Lessons From the COVID-19 Pandemic
PURPOSE OF REVIEW: The coronavirus disease 2019 (COVID-19) pandemic has popularized the usage of hydroxychloroquine and chloroquine (HCQ/CQ) as treatments for COVID-19. Previously used as anti-malarial and now commonly used in rheumatologic conditions, preliminary in vitro studies have demonstrated...
Autores principales: | Gagnon, Luke R., Sadasivan, Chandu, Yogasundaram, Haran, Oudit, Gavin Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514702/ https://www.ncbi.nlm.nih.gov/pubmed/36167917 http://dx.doi.org/10.1007/s11897-022-00581-y |
Ejemplares similares
-
Missed Opportunities in the Diagnosis of Heart Failure: Evaluation of Pathways to Determine Sources of Delay to Specialist Evaluation
por: Kwok, Chun Shing, et al.
Publicado: (2022) -
Optimization of Drug Therapy for Heart Failure With Reduced Ejection Fraction Based on Gender
por: Iacoviello, Massimo, et al.
Publicado: (2022) -
The Emerging Role of Cardiac Conduction System Pacing as a Treatment for Heart Failure
por: Ali, Nadine, et al.
Publicado: (2020) -
Epidemiology of Asymptomatic Pre-heart Failure: a Systematic Review
por: Bergamasco, Aurore, et al.
Publicado: (2022) -
Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure
por: Patel, Vaibhav B., et al.
Publicado: (2012)